NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.
CASRN: 147536-97-8

Drug Levels and Effects
Summary of Use during Lactation
There is little published experience with bosentan during breastfeeding. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
A 23-year-old woman with congenital heart disease and pulmonary hypertension was treated during pregnancy with bosentan and sildenafil in unspecified dosages. These drugs and warfarin were continued postpartum. Her infant was delivered at 30 weeks by cesarean section and weighed 1.41 kg at birth. She nursed the infant in the neonatal intensive care unit for 11 weeks "with good outcome" according to the authors, but the infant died at 26 weeks from a respiratory syncytial virus infection.[1]
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Molelekwa V, Akhter P, McKenna P et al. Eisenmenger's syndrome in a 27 week pregnancy--management with bosentan and sildenafil. Ir Med J. 2005;98:87-8. [PubMed: 15869069]
Substance Identification
Substance Name
Bosentan
CAS Registry Number
147536-97-8
Drug Class
- Breast Feeding
- Antihypertensive Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Fedratinib[Drugs and Lactation Database (...]Review Fedratinib. Drugs and Lactation Database (LactMed). 2006
- Review Ticagrelor[Drugs and Lactation Database (...]Review Ticagrelor. Drugs and Lactation Database (LactMed). 2006
- Review Nilotinib[Drugs and Lactation Database (...]Review Nilotinib. Drugs and Lactation Database (LactMed). 2006
- Review Carvedilol[Drugs and Lactation Database (...]Review Carvedilol. Drugs and Lactation Database (LactMed). 2006
- Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.[J Pharmacol Exp Ther. 1994]Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, Cassal JM, Hirth G, Müller M, Neidhart W. J Pharmacol Exp Ther. 1994 Jul; 270(1):228-35.
- Bosentan - Drugs and Lactation Database (LactMed)Bosentan - Drugs and Lactation Database (LactMed)
Your browsing activity is empty.
Activity recording is turned off.
See more...